Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation

Name: Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation
License: Public Domain

Bristol-Myers Squibb

ClinicalTrials.gov · Datasets · License: Public Domain

advanced cancer, metastatic cancer, malignant neoplasm, adagrasib, expanded access

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 802503
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.